![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/08/2909617/0/en/Avacta-Announces-the-Appointment-of-Darlene-Deptula-Hicks-as-Non-Executive-Director-of-the-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/04/05/2858739/0/en/Avacta-Group-AVA6000-Abstract-Release-by-AACR-and-Full-Presentation-Update.html
https://www.globenewswire.com//news-release/2024/03/05/2840928/0/en/Updated-Results-from-Single-Agent-Phase-1-Clinical-Trial-of-Peptide-Drug-Conjugate-AVA6000-to-be-Presented-in-a-Poster-at-the-American-Association-of-Cancer-Research-AACR-Annual-Me.html
https://www.globenewswire.com//news-release/2023/12/19/2798406/0/en/Appointment-of-Chief-Business-Officer.html
https://www.globenewswire.com//news-release/2023/12/13/2795421/0/en/ALS-6000-101-Phase-1a-Three-Weekly-Dose-Escalation-Safety-Study-Data.html
https://www.globenewswire.com//news-release/2023/10/05/2755071/0/en/Avacta-to-present-promising-new-data-from-Affimer-and-pre-CISIONTM-platform-assets-at-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html